tiprankstipranks
Milestone Pharmaceuticals Welcomes New Directors and Auditor
Company Announcements

Milestone Pharmaceuticals Welcomes New Directors and Auditor

Pick the best stocks and maximize your portfolio:

Milestone Pharmaceuticals (MIST) has provided an update.

During the 2024 Annual Meeting of Shareholders, the company’s shareholders elected new directors and approved PricewaterhouseCoopers LLP as the auditor for the next year. The elected directors include Joseph Oliveto, Lisa M. Giles, and others, with significant support, while Robert J. Wills had a notable number of votes withheld. Post-meeting, committee reassignments were made, including Stuart M. Duty joining the Nominating and Corporate Governance Committee. Additionally, the company publicly announced Mr. Papa’s appointment to the Board on September 4, 2024.

See more data about MIST stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyMilestone Pharmaceuticals files $250M mixed securities shelf
TipRanks Canadian Auto-Generated NewsdeskMilestone Pharmaceuticals Prepares for CARDAMYST Approval
TheFlyMilestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App